Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson`s disease


Autoria(s): PREDIGER, Rui D. S.; ROJAS-MAYORQUIN, Argelia E.; AGUIAR JR., Aderbal S.; CHEVARIN, Caroline; MONGEAU, Raymond; HAMON, Michel; LANFUMEY, Laurence; BEL, Elaine Del; MURAMATSU, Hisako; COURTY, Jose; RAISMAN-VOZARI, Rita
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

There is considerable evidence showing that the neurodegenerative processes that lead to sporadic Parkinson`s disease (PD) begin many years before the appearance of the characteristic motor symptoms and that impairments in olfactory, cognitive and motor functions are associated with time-dependent disruption of dopaminergic neurotransmission in different brain areas. Midkine is a 13-kDa retinoic acid-induced heparin-binding growth factor involved in many biological processes in the central nervous system such as cell migration, neurogenesis and tissue repair. The abnormal midkine expression may be associated with neurochemical dysfunction in the dopaminergic system and cognitive impairments in rodents. Here, we employed adult midkine knockout mice (Mdk(-/-)) to further investigate the relevance of midkine in dopaminergic neurotransmission and in olfactory, cognitive and motor functions. Mdk(/-) mice displayed pronounced impairments in their olfactory discrimination ability and short-term social recognition memory with no gross motor alterations. Moreover, the genetic deletion of midkine decreased the expression of the enzyme tyrosine hydroxylase in the substantia nigra reducing partially the levels of dopamine and its metabolites in the olfactory bulb and striatum of mice. These findings indicate that the genetic deletion of midkine causes a partial loss of dopaminergic neurons and depletion of dopamine, resulting in olfactory and memory deficits with no major motor impairments. Therefore, Mdk(-/-) mice may represent a promising animal model for the study of the early stages of PD and for testing new therapeutic strategies to restore sensorial and cognitive processes in PD.

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil

Programa de Apoio aos Nucleos de Excelencia (PRONEX), Brazil

Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC), Brazil

CONACYT (Mexico)[76101]

CONACYT (Mexico)[93485]

CAPES-COFECUB (France/Brazil)[491/2005]

CAPES-COFECUB (France/Brazil)[681/2010]

FAPESP-INSERM[55092-9/2008]

Identificador

JOURNAL OF NEURAL TRANSMISSION, v.118, n.8, p.1215-1225, 2011

0300-9564

http://producao.usp.br/handle/BDPI/26245

10.1007/s00702-010-0568-3

http://dx.doi.org/10.1007/s00702-010-0568-3

Idioma(s)

eng

Publicador

SPRINGER WIEN

Relação

Journal of Neural Transmission

Direitos

restrictedAccess

Copyright SPRINGER WIEN

Palavras-Chave #Parkinson`s disease #Midkine #Olfactory discrimination #Learning and memory #Motor #Animal model #Knockout mice #1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE RAT MODEL #SOCIAL RECOGNITION MEMORY #OLFACTORY-BULB #NEUROTROPHIC FACTOR #WORKING-MEMORY #ANIMAL-MODELS #DOPAMINE #RECEPTORS #NEURONS #MPTP #Clinical Neurology #Neurosciences
Tipo

article

original article

publishedVersion